Advancements in Duchenne Drug Development and FDA Approved Therapies

When:
September 7, 2021 3:00PM

Join us for a live webinar–Advancements in Duchenne Drug Development and FDA Approved Therapies–as part of our Community Webinar Series. Our speaker, Han C. Phan, MD, will go into detail about advancements in Duchenne drug development and FDA approved therapies to the Jett Foundation community, and then engage in a conversation to capture comments and feedback.

Featured Speaker

Han C. Phan, MD

Neurologist, Rare Disease Research Unit

Dr. Han Phan is a pediatric neurologist and sleep specialist who is highly passionate about clinical trials in neuromuscular diseases, specifically Duchenne Muscular Dystrophy and Spinal Muscular Atrophy. She is a member of the Pediatric Advisory Board at the FDA and a guest researcher at the CDC Newborn Screening Branch. She is currently an Associate Professor at the University of Alabama, and co director of MDA clinic. At Rare Disease Research center, she is the principal investigator overseeing ongoing studies in neuromuscular patients.

Community Webinar Series Logo

Jett Foundation invites all members of the Duchenne community to attend our Community Webinar Series! This series is focused on topics tailored to help individuals and families impacted by Duchenne learn more about care, clinical trials, resources, and support. We are committed to providing these 1-hour presentations to empower individuals and families with the tools and resources needed to be their own best advocates.

View Our Upcoming Educational Webinars

Please contact danielle@jettfoundation.org with any questions or if you’d like to become a future speaker at one of our community webinars. We look forward to having you participate in these virtual community engagement events!